Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: loss of DAME and IL-1 chemotaxis. 1993

G B Stefano, and T V Bilfinger
Multidisciplinary Center for the Study of Aging, State University of New York/College at Old Westbury 11568.

Cardiopulmonary bypass (CPB) induces both cellular immunosuppression and an inflammatory response. In an effort to better characterize CPB-induced immune dysfunction, we examined the chemotaxic ability of human granulocytes and macrophages to D-Ala2-Met-enkephalin (DAME) and interleukin (IL)-1 alpha with computer-assisted microscopic image analysis before, during and after CPB. Spontaneous granulocyte and macrophage activation increased from 6% and 8% (before) to 52% and 44% (during) and then 39% and 31% after (38 h) CPB, respectively. These activated cells, characterized by conformational changes and locomotion, exhibited chemokinesis. Furthermore, no direct response to either DAME or IL-1 alpha was observed in the bypass and postoperative specimens. Cellular velocity was 0.14 and 0.07 microns s-1 for control spontaneously activated granulocytes and macrophages, respectively, and equal to the velocity observed for DAME and IL-1 alpha exposed cells, during and after CPB. CPB-unexposed cells, influenced only by the chemotaxic agents, exhibited a 3-4-fold increase in their velocity. Additionally, the migratory path of the activated cells obtained during and after CPB exhibited chemokinesis, rather than chemotaxis, when placed in a concentration gradient of either signal molecule. Cells exposed to fentanyl, the anesthetic agent, exhibited the same behavior as controls, as did those treated with morphine sulphate. However, at higher concentrations (> or = 10 ng ml-1) fentanyl and morphine reduced granulocyte and macrophage activity, demonstrating that CPB caused the opposite effect of fentanyl and also that CPB exposure overcame the pharmacological inhibitory effect of the mu opiate ligands.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D004744 Enkephalin, Methionine One of the endogenous pentapeptides with morphine-like activity. It differs from LEU-ENKEPHALIN by the amino acid METHIONINE in position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN. Methionine Enkephalin,5-Methionine Enkephalin,Met(5)-Enkephalin,Met-Enkephalin,5 Methionine Enkephalin,Enkephalin, 5-Methionine,Met Enkephalin
D005283 Fentanyl A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) Phentanyl,Duragesic,Durogesic,Fentanest,Fentanyl Citrate,Fentora,R-4263,Sublimaze,Transmucosal Oral Fentanyl Citrate,R 4263,R4263
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G B Stefano, and T V Bilfinger
February 2004, American journal of physiology. Renal physiology,
G B Stefano, and T V Bilfinger
October 1977, Archives of pathology & laboratory medicine,
G B Stefano, and T V Bilfinger
January 1976, Surgical forum,
G B Stefano, and T V Bilfinger
August 1980, Infection and immunity,
G B Stefano, and T V Bilfinger
December 2010, The Journal of clinical investigation,
G B Stefano, and T V Bilfinger
January 1976, Surgical forum,
G B Stefano, and T V Bilfinger
December 1993, Biomaterials,
G B Stefano, and T V Bilfinger
May 1980, Clinical and experimental immunology,
G B Stefano, and T V Bilfinger
January 1984, Kroc Foundation series,
Copied contents to your clipboard!